MAK Capital Fund LP·SCHEDULE 13G/A

Mar 30, 5:31 PM ET

Protalix BioTherapeutics, Inc. SCHEDULE 13G/A

SCHEDULE 13G/A · MAK Capital Fund LP · Filed Mar 30, 2026

Documents

2 files